Scientists at the UK Dementia Research Institute are utilizing artificial intelligence to expedite the process of finding drugs for neurological disorders. The research involves analyzing patient data, such as voice recordings and eye scans, as well as stem cell-derived brain cells, to identify potential drug repurposing opportunities for conditions including Motor Neurone Disease (MND).
The goal of employing AI algorithms to detect disease patterns and predict suitable medications is to accelerate the discovery of effective treatments, with hopes of achieving this in years rather than decades. This approach is being explored in trials like MND-SMART, which tests multiple drugs concurrently rather than using placebo groups.
Additionally, the institute is compiling a database of individuals with conditions like Parkinson's, Dementia, and MND. This database includes clinical data such as iris scans and voice recordings, with AI being used to process this information to identify early signs of potential future health issues. Blood samples are also collected to grow brain cells, on which existing drugs are tested.
